Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation

American Journal of Pathology

Volumn 182, Issue 5, 2013, Pages 1696-1704

  Nayak, Lalitha ^a,b   Goduni, Lediana ^a   Takami, Yoichi ^a   Sharma, Nikunj ^a   Kapil, Parul ^c   Jain, Mukesh K ^a   Mahabeleshwar, Ganapati H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DERMATITIS; ENZYME ACTIVITY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

ACUTE DISEASE; ANIMALS; CARRAGEENAN; CELL LINE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EDEMA; GENE EXPRESSION REGULATION; HEMIZYGOTE; HUMANS; INFLAMMATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; SEPSIS; SKIN; TRANSCRIPTION, GENETIC;

EID: 84876518079     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.029     Document Type: Article

References (41)

1. D.L. Laskin, V.R. Sunil, C.R. Gardner, and J.D. Laskin Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51 2011 267 288
2. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
3. N.V. Serbina, and E.G. Pamer Coordinating innate immune cells to optimize microbial killing Immunity 29 2008 672 674
4. N.V. Serbina, T. Jia, T.M. Hohl, and E.G. Pamer Monocyte-mediated defense against microbial pathogens Annu Rev Immunol 26 2008 421 452
5. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 2012 787 795
6. T. Glaros, M. Larsen, and L. Li Macrophages and fibroblasts during inflammation, tissue damage and organ injury Front Biosci 14 2009 3988 3993
7. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu Rev Physiol 72 2010 219 246
8. J.I. Odegaard, and A. Chawla Alternative macrophage activation and metabolism Annu Rev Pathol 6 2011 275 297
9. P.J. Murray, and T.A. Wynn Protective and pathogenic functions of macrophage subsets Nat Rev Immunol 11 2011 723 737
10. S. Vallabhapurapu, and M. Karin Regulation and function of NF-kappaB transcription factors in the immune system Annu Rev Immunol 27 2009 693 733
11. R. Sen, and D. Baltimore Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism Cell 47 1986 921 928
12. M. Kengatharan, S.J. De Kimpe, and C. Thiemermann Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages Br J Pharmacol 117 1996 1163 1170
13. C. Mehlin, C.M. Headley, and S.J. Klebanoff An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization J Exp Med 189 1999 907 918
14. T. Lawrence, D.W. Gilroy, P.R. Colville-Nash, and D.A. Willoughby Possible new role for NF-kappaB in the resolution of inflammation Nat Med 7 2001 1291 1297
15. T. Lawrence, and C. Fong The resolution of inflammation: anti-inflammatory roles for NF-kappaB Int J Biochem Cell Biol 42 2010 519 523
16. A. Kumar, Y. Takada, A.M. Boriek, and B.B. Aggarwal Nuclear factor-kappaB: its role in health and disease J Mol Med (Berl) 82 2004 434 448
17. J.S. Orange, O. Levy, and R.S. Geha Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation Immunol Rev 203 2005 21 37
18. K.D. Brown, E. Claudio, and U. Siebenlist The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis Arthritis Res Ther 10 2008 212
19. E.T. Wong, and V. Tergaonkar Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential Clin Sci (Lond) 116 2009 451 465
20. N. Ghosh, R. Chaki, V. Mandal, G.D. Lin, and S.C. Mandal Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases Int Rev Immunol 29 2010 4 37
21. E.T. Andreakos, B.M. Foxwell, F.M. Brennan, R.N. Maini, and M. Feldmann Cytokines and anti-cytokine biologicals in autoimmunity: present and future Cytokine Growth Factor Rev 13 2002 299 313
22. E. Andreakos, P.C. Taylor, and M. Feldmann Monoclonal antibodies in immune and inflammatory diseases Curr Opin Biotechnol 13 2002 615 620
23. M. Feldmann, E. Andreakos, C. Smith, J. Bondeson, S. Yoshimura, S. Kiriakidis, C. Monaco, C. Gasparini, S. Sacre, A. Lundberg, E. Paleolog, N.J. Horwood, F.M. Brennan, and B.M. Foxwell Is NF-kappaB a useful therapeutic target in rheumatoid arthritis? Ann Rheum Dis 61 Suppl 2 2002 ii13 ii18
24. B.B. McConnell, and V.W. Yang Mammalian Kruppel-like factors in health and diseases Physiol Rev 90 2010 1337 1381
25. K.P. Anderson, C.B. Kern, S.C. Crable, and J.B. Lingrel Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Kruppel-like factor: identification of a new multigene family Mol Cell Biol 15 1995 5957 5965
26. H. Das, A. Kumar, Z. Lin, W.D. Patino, P.M. Hwang, M.W. Feinberg, P.K. Majumder, and M.K. Jain Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes Proc Natl Acad Sci U S A 103 2006 6653 6658
27. G.H. Mahabeleshwar, D. Kawanami, N. Sharma, Y. Takami, G. Zhou, H. Shi, L. Nayak, D. Jeyaraj, R. Grealy, M. White, R. McManus, T. Ryan, P. Leahy, Z. Lin, S.M. Haldar, G.B. Atkins, H.R. Wong, J.B. Lingrel, and M.K. Jain The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock Immunity 34 2011 715 728
28. G.H. Mahabeleshwar, M.A. Qureshi, Y. Takami, N. Sharma, J.B. Lingrel, and M.K. Jain A myeloid hypoxia-inducible factor 1alpha-Kruppel-like factor 2 pathway regulates gram-positive endotoxin-mediated sepsis J Biol Chem 287 2012 1448 1457
29. G.B. Atkins, Y. Wang, G.H. Mahabeleshwar, H. Shi, H. Gao, D. Kawanami, V. Natesan, Z. Lin, D.I. Simon, and M.K. Jain Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis Circ Res 103 2008 690 693
30. C.T. Kuo, M.L. Veselits, and J.M. Leiden LKLF: a transcriptional regulator of single-positive T cell quiescence and survival Science 277 1997 1986 1990
31. T. Cramer, Y. Yamanishi, B.E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V.H. Haase, R. Jaenisch, M. Corr, V. Nizet, G.S. Firestein, H.P. Gerber, N. Ferrara, and R.S. Johnson HIF-1alpha is essential for myeloid cell-mediated inflammation Cell 112 2003 645 657
32. A.D. Cook, E.L. Braine, and J.A. Hamilton The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response J Immunol 171 2003 4816 4823
33. H.L. Pahl Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
34. A. Ding, S. Hwang, H.M. Lander, and Q.W. Xie Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B J Leukoc Biol 57 1995 174 179
35. B.S. Taylor, M.E. de Vera, R.W. Ganster, Q. Wang, R.A. Shapiro, S.M. Morris Jr., T.R. Billiar, and D.A. Geller Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene J Biol Chem 273 1998 15148 15156
36. Z. Cao, X. Sun, B. Icli, A.K. Wara, and M.W. Feinberg Role of Kruppel-like factors in leukocyte development, function, and disease Blood 116 2010 4404 4414
37. A. Kumar, Z. Lin, S. SenBanerjee, and M.K. Jain Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases Mol Cell Biol 25 2005 5893 5903
38. S. SenBanerjee, Z. Lin, G.B. Atkins, D.M. Greif, R.M. Rao, A. Kumar, M.W. Feinberg, Z. Chen, D.I. Simon, F.W. Luscinskas, T.M. Michel, M.A. Gimbrone Jr., G. Garcia-Cardena, and M.K. Jain KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation J Exp Med 199 2004 1305 1315
39. C.T. Kuo, M.L. Veselits, K.P. Barton, M.M. Lu, C. Clendenin, and J.M. Leiden The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis Genes Dev 11 1997 2996 3006
40. M.A. Weinreich, K. Takada, C. Skon, S.L. Reiner, S.C. Jameson, and K.A. Hogquist KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors Immunity 31 2009 122 130
41. M. Das, J. Lu, M. Joseph, R. Aggarwal, S. Kanji, B.K. McMichael, B.S. Lee, S. Agarwal, A. Ray-Chaudhury, O.H. Iwenofu, P. Kuppusamy, V.J. Pompili, M.K. Jain, and H. Das Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-1beta-induced arthritis Curr Mol Med 12 2012 113 125